Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol:
IL7
Name:
interleukin 7
Location:
08q21.13
Locus Group:
protein-coding gene
Gene Type:
Protein Coding
Locus Type:
gene with protein product
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all
Clinical Studies
| NCT Number | Status | Brief Title | View |
|---|---|---|---|
| NCT00521287 | Impaired Immunity in Patients With Cancer Influence of Cancer Stage Chemotherapy and Cytomegalovirus Infection | View | |
| NCT04664179 | EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma | View | |
| NCT04833504 | Clinical Follow-up Study of CD19 CAR-T Expressing IL7 and CCL19 for Relapsed or Refractory B Cell Lymphoma | View | |
| NCT05643547 | Immunophenotypic Evaluation of IL-7R α in Acute Leukaemia | View | |
| NCT00168207 | IL-7 Receptor Polymorphisms and Immune Recovery With HAART | View | |
| NCT03513952 | Atezolizumab and CYT107 in Treating Participants With Locally Advanced Inoperable or Metastatic Urothelial Carcinoma | View | |
| NCT04381741 | CD19 CAR-T Expressing IL7 and CCL19 Combined With PD1 mAb for Relapsed or Refractory Diffuse Large B Cell Lymphoma | View | |
| NCT03198546 | GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression | View | |
| NCT03778346 | Integrin β7 BCMA CS1 CD38 and CD138 as the Single or Compound Targets for the Fourth Genenation of CAR-T Cells | View | |
| NCT05410717 | CLDN6GPC3MesothelinAXL-CAR-NK Cell Therapy for Advanced Solid Tumors | View | |
| NCT05716295 | A Dose EscalationExpansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors | View | |
| NCT03932565 | Interventional Therapy Sequential With the Fourth-generation CAR-T Targeting Nectin4FAP for Malignant Solid Tumors | View |